GENERALIZED MYASTHENIA GRAVIS
Clinical trials for GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for muscle weakness disease
Disease control CompletedThis study tested a drug called rozanolixizumab in 200 adults with generalized myasthenia gravis, a condition causing muscle weakness. The goal was to see if the drug improves daily activities and is safe compared to a placebo. Results showed it may help reduce symptoms like trou…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 17, 2026 07:54 UTC
-
New injection shows promise for Long-Term control of rare Muscle-Weakening disease
Disease control CompletedThis study tested the long-term safety of a drug called efgartigimod in 184 adults with generalized myasthenia gravis, a condition that causes muscle weakness. Participants received repeated injections over weeks, as needed, to see if the treatment was safe and helped with daily …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 17, 2026 07:53 UTC
-
Home injection study shows promise for myasthenia gravis patients
Disease control CompletedThis study looked at whether 62 adults with generalized myasthenia gravis could safely give themselves the drug rozanolixizumab at home after training. Participants used either a syringe driver or manual push method. The main goal was to see if they could correctly choose the inj…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 17, 2026 07:36 UTC
-
New shot option for MG patients: easier dosing, same control?
Disease control CompletedThis study looked at whether people with generalized myasthenia gravis could safely switch from an IV infusion to a daily shot of zilucoplan. 26 adults who were stable on IV treatment took part. The main goal was to check for side effects and see if the switch kept their symptoms…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New dosing strategy aims to keep myasthenia gravis symptoms under control
Disease control CompletedThis study tested two ways of giving the drug efgartigimod to people with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. One group received the drug on a regular, continuous schedule, while the other got it in cycles. The goal was to see which appro…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New Auto-Injector lets MG patients Self-Dose at home
Symptom relief CompletedThis study tested whether people with generalized myasthenia gravis (gMG) can safely and effectively use an auto-injector to give themselves the drug zilucoplan at home. 31 adults who were already taking zilucoplan participated. The main goal was to see if they could successfully…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC